First, when COTL-1 was re-expressed in mesenchymal mouse breast cancer cells (FE 1.2) and human MCF7 breast cancer cells, it led to the activation of the growth-suppressor gene interleukin-24 (IL-24). The gene discussed is COTL1; the disease is breast carcinoma.